SEVERE HEMOPHILIA B
Clinical trials for SEVERE HEMOPHILIA B explained in plain language.
Never miss a new study
Get alerted when new SEVERE HEMOPHILIA B trials appear
Sign up with your email to follow new studies for SEVERE HEMOPHILIA B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could cut bleeding episodes in severe hemophilia
Disease control OngoingThis phase 3 trial tests fitusiran, an injectable drug, in 91 males aged 12 and older with severe hemophilia A or B, with or without inhibitors. Participants first receive standard care for 6 months, then switch to fitusiran for about 3 years. The goal is to see if fitusiran redu…
Matched conditions: SEVERE HEMOPHILIA B
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Massive hemophilia study aims to uncover hidden costs and care gaps in china
Knowledge-focused OngoingThis study is observing 500 male patients aged 12 and older with severe hemophilia A or B across China. Researchers are collecting data on treatment patterns, costs, and quality of life to understand the true burden of the disease. The goal is to identify gaps in care and help im…
Matched conditions: SEVERE HEMOPHILIA B
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC